Stereotactic Radiosurgery With Versus Without Embolization for Brain Arteriovenous Malformations
Language English Country United States Media print
Document type Journal Article
PubMed
33017465
DOI
10.1093/neuros/nyaa418
PII: 5918097
Knihovny.cz E-resources
- Keywords
- Arteriovenous malformation, Embolization, Endovascular, Stereotactic radiosurgery, Stroke,
- MeSH
- Adult MeSH
- Intracranial Arteriovenous Malformations therapy MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Radiosurgery methods MeSH
- Retrospective Studies MeSH
- Embolization, Therapeutic methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Prior comparisons of brain arteriovenous malformations (AVMs) treated using stereotactic radiosurgery (SRS) with or without embolization were inherently flawed, due to differences in the pretreatment nidus volumes. OBJECTIVE: To compare the outcomes of embolization and SRS, vs SRS alone for AVMs using pre-embolization malformation features. METHODS: We retrospectively reviewed International Radiosurgery Research Foundation AVM databases from 1987 to 2018. Patients were categorized into the embolization and SRS (E + SRS) or SRS alone (SRS-only) cohorts. The 2 cohorts were matched in a 1:1 ratio using propensity scores. Primary outcome was defined as AVM obliteration. Secondary outcomes were post-SRS hemorrhage, all-cause mortality, radiologic and symptomatic radiation-induced changes (RIC), and cyst formation. RESULTS: The matched cohorts each comprised 101 patients. Crude AVM obliteration rates were similar between the matched E + SRS vs SRS-only cohorts (48.5% vs 54.5%; odds ratio = 0.788, P = .399). Cumulative probabilities of obliteration at 3, 4, 5, and 6 yr were also similar between the E + SRS (33.0%, 46.4%, 56.2%, and 60.8%, respectively) and SRS-only (32.9%, 46.2%, 56.0%, and 60.6%, respectively) cohorts (subhazard ratio (SHR) = 1.005, P = .981). Cumulative probabilities of radiologic RIC at 3, 4, 5, and 6 yr were lower in the E + SRS (25.0%, 25.7%, 26.7%, and 26.7%, respectively) vs SRS-only (45.3%, 46.2%, 47.8%, and 47.8%, respectively) cohort (SHR = 0.478, P = .004). Symptomatic and asymptomatic embolization-related complication rates were 8.3% and 18.6%, respectively. Rates of post-SRS hemorrhage, all-cause mortality, symptomatic RIC, and cyst formation were similar between the matched cohorts. CONCLUSION: This study refutes the prevalent notion that AVM embolization negatively affects the likelihood of obliteration after SRS.
Department of Neurological Surgery University of Virginia Charlottesville Virginia
Department of Neurosurgery Na Homolce Hospital Prague Czech Republic
Department of Neurosurgery New York University New York New York
Department of Neurosurgery Pennsylvania State University Hershey Pennsylvania
Department of Neurosurgery Taipei Veterans General Hospital Taipei Taiwan
Department of Neurosurgery The Jewish Hospital Cincinnati Ohio
Department of Neurosurgery Université de Sherbrooke Centre de recherche du CHUS Sherbrooke Canada
Department of Neurosurgery University of Louisville Louisville Kentucky
Department of Neurosurgery University of Pennsylvania Philadelphia Pennsylvania
Department of Neurosurgery University of Puerto Rico San Juan Puerto Rico
Department of Neurosurgery West Virginia University Morgantown West Virginia
Department of Radiation Oncology Pennsylvania State University Hershey Pennsylvania
Department of Radiation Oncology The Mayo Clinic Jacksonville Florida
Department of Radiation Oncology University of Louisville Louisville Kentucky
School of Medicine National Yang Ming University Taipei Taiwan
References provided by Crossref.org